Document Detail


Effects of growth hormone releasing hormone on insulin action and insulin secretion in a hypopituitary patient evaluated by the clamp technique.
MedLine Citation:
PMID:  1519429     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of growth hormone releasing hormone (GHRH-44) therapy on insulin action and secretion was evaluated in a hypopituitary patient after one month and one year of treatment. Hepatic and peripheral insulin action was studied with the hyperinsulinemic-euglycemic clamp in combination with [6,6-2H2]glucose tracer infusion. First and second phase insulin secretion was assessed with the hyperglycemic clamp. Prior to GHRH-44 therapy the hypopituitary patient had higher insulin mediated glucose disposal rate and lower basal and stimulated insulin concentrations by more than two standard deviations from the mean of a control group. Following therapy there was no change in basal hepatic glucose production; however, there was evidence of diminished peripheral insulin action. This was manifested by decreased insulin mediated glucose disposal during the hyperinsulinemic-euglycemic clamp, and increased insulin secretion during the hyperglycemic clamp. We conclude that GHRH-44 therapy in this patient was associated with decreased peripheral insulin action which was compensated for by increased insulin secretion.
Authors:
S Arslanian; S Kalhan
Related Documents :
3546379 - Equivalence of the insulin sensitivity index in man derived by the minimal model method...
8593939 - Long-term normoglycemic remission in black newly diagnosed niddm subjects.
10801929 - High chromium yeast supplementation improves glucose tolerance in pigs by decreasing he...
22300579 - Quantitative analysis of proteins in the tear fluid of patients with diabetic retinopathy.
22621919 - Non-invasive assessment of microcirculation by sidestream dark field imaging as a marke...
22383749 - Chronic kidney disease, insulin resistance, and incident diabetes in older adults.
2189419 - Effects of pioglitazone on glucose and lipid metabolism in wistar fatty rats.
21099309 - Activation of the amp-activated protein kinase enhances glucose-stimulated insulin secr...
1769439 - Changes in cholinergic sweat gland activation in diabetic neuropathy identified by comp...
Publication Detail:
Type:  Case Reports; Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Acta endocrinologica     Volume:  127     ISSN:  0001-5598     ISO Abbreviation:  Acta Endocrinol.     Publication Date:  1992 Jul 
Date Detail:
Created Date:  1992-10-08     Completed Date:  1992-10-08     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0370312     Medline TA:  Acta Endocrinol (Copenh)     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  93-6     Citation Subset:  IM    
Affiliation:
Division of Pediatric Endocrinology, Metabolism and Diabetes Mellitus, Children's Hospital, University of Pittsburgh, PA 15213.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Child
Female
Glucose Clamp Technique
Growth Hormone-Releasing Hormone / pharmacology*,  therapeutic use
Humans
Hypopituitarism / blood*,  drug therapy,  physiopathology*
Insulin / blood*,  physiology*
Time Factors
Grant Support
ID/Acronym/Agency:
5 MO1-RR00086-25/RR/NCRR NIH HHS; P-50-HD11089/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
11061-68-0/Insulin; 9034-39-3/Growth Hormone-Releasing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Decrease of testosterone level during an experimental African trypanosomiasis: involvement of a test...
Next Document:  Deformability of the erythrocyte membrane in patients with myelodysplastic syndromes.